123 related articles for article (PubMed ID: 9053586)
1. Anxiolytic effects of dotarizine, a possible antimigraine drug.
Petkov VD; Belcheva S; Konstantinova E
Methods Find Exp Clin Pharmacol; 1995 Dec; 17(10):659-68. PubMed ID: 9053586
[TBL] [Abstract][Full Text] [Related]
2. Effects on nociception of the Ca2+ and 5-HT antagonist dotarizine and other 5-HT receptor agonists and antagonists.
Belcheva S; Petkov VD; Konstantinova E; Petkov VV; Boyanova E
Acta Physiol Pharmacol Bulg; 1995; 21(4):93-8. PubMed ID: 8830881
[TBL] [Abstract][Full Text] [Related]
3. Behavioral effects of the Ca2+/5-HT antagonist dotarizine.
Petkov VD; Belcheva S; Konstantinova E; Vaglenova J; Petkov VV
Acta Physiol Pharmacol Bulg; 1994; 20(1):9-17. PubMed ID: 7892769
[TBL] [Abstract][Full Text] [Related]
4. Acute and chronic effects of gepirone and fluoxetine in rats tested in the elevated plus-maze: an ethological analysis.
Silva RC; Brandão ML
Pharmacol Biochem Behav; 2000 Feb; 65(2):209-16. PubMed ID: 10672971
[TBL] [Abstract][Full Text] [Related]
5. Effects of fluoxetine given chronically on the responsiveness of 5-HT receptor subpopulations to their agonists.
Maj J; Moryl E
Eur Neuropsychopharmacol; 1993 Jun; 3(2):85-94. PubMed ID: 8364353
[TBL] [Abstract][Full Text] [Related]
6. 8-OH-DPAT, but not deramciclane, antagonizes the anxiogenic-like action of paroxetine in an elevated plus-maze.
Kõks S; Beljajev S; Koovit I; Abramov U; Bourin M; Vasar E
Psychopharmacology (Berl); 2001 Jan; 153(3):365-72. PubMed ID: 11271409
[TBL] [Abstract][Full Text] [Related]
7. Dose dependent effects of serotonergic agents on anxiety.
Kolcsar M; Gáll Z; Dogaru MT
Acta Physiol Hung; 2014 Dec; 101(4):479-87. PubMed ID: 25532957
[TBL] [Abstract][Full Text] [Related]
8. 5-HT1A receptors are differentially involved in the anxiolytic- and antidepressant-like effects of 8-OH-DPAT and fluoxetine in the rat.
De Vry J; Schreiber R; Melon C; Dalmus M; Jentzsch KR
Eur Neuropsychopharmacol; 2004 Dec; 14(6):487-95. PubMed ID: 15589388
[TBL] [Abstract][Full Text] [Related]
9. The selective serotonin (5-HT)1A receptor ligand, S15535, displays anxiolytic-like effects in the social interaction and Vogel models and suppresses dialysate levels of 5-HT in the dorsal hippocampus of freely-moving rats. A comparison with other anxiolytic agents.
Dekeyne A; Brocco M; Adhumeau A; Gobert A; Millan MJ
Psychopharmacology (Berl); 2000 Sep; 152(1):55-66. PubMed ID: 11041316
[TBL] [Abstract][Full Text] [Related]
10. Meta-chlorophenylpiperazine induced changes in locomotor activity are mediated by 5-HT1 as well as 5-HT2C receptors in mice.
Gleason SD; Shannon HE
Eur J Pharmacol; 1998 Jan; 341(2-3):135-8. PubMed ID: 9543230
[TBL] [Abstract][Full Text] [Related]
11. Evidence for accelerated desensitisation of 5-HT(2C) receptors following combined treatment with fluoxetine and the 5-HT(1A) receptor antagonist, WAY 100,635, in the rat.
Bristow LJ; O'Connor D; Watts R; Duxon MS; Hutson PH
Neuropharmacology; 2000 Apr; 39(7):1222-36. PubMed ID: 10760364
[TBL] [Abstract][Full Text] [Related]
12. The pharmacology of VA21B7: an atypical 5-HT3 receptor antagonist with anxiolytic-like properties in animal models.
Artaiz I; Romero G; Zazpe A; Monge A; Calderó JM; Roca J; Lasheras B; Del Río J
Psychopharmacology (Berl); 1995 Jan; 117(2):137-48. PubMed ID: 7753959
[TBL] [Abstract][Full Text] [Related]
13. Serotonergic mechanisms involved in the exploratory behaviour of mice in a fully automated two-compartment black and white text box.
Sánchez C
Pharmacol Toxicol; 1995 Jul; 77(1):71-8. PubMed ID: 8532615
[TBL] [Abstract][Full Text] [Related]
14. Risk assessment behaviour: evaluation of utility in the study of 5-HT-related drugs in the rat elevated plus-maze test.
Griebel G; Rodgers RJ; Perrault G; Sanger DJ
Pharmacol Biochem Behav; 1997 Aug; 57(4):817-27. PubMed ID: 9259011
[TBL] [Abstract][Full Text] [Related]
15. Anxiety-like effects induced by acute fluoxetine, sertraline or m-CPP treatment are reversed by pretreatment with the 5-HT2C receptor antagonist SB-242084 but not the 5-HT1A receptor antagonist WAY-100635.
Bagdy G; Graf M; Anheuer ZE; Modos EA; Kantor S
Int J Neuropsychopharmacol; 2001 Dec; 4(4):399-408. PubMed ID: 11806866
[TBL] [Abstract][Full Text] [Related]
16. Buspirone modulates basal and fluoxetine-stimulated dialysate levels of dopamine, noradrenaline and serotonin in the frontal cortex of freely moving rats: activation of serotonin1A receptors and blockade of alpha2-adrenergic receptors underlie its actions.
Gobert A; Rivet JM; Cistarelli L; Melon C; Millan MJ
Neuroscience; 1999; 93(4):1251-62. PubMed ID: 10501449
[TBL] [Abstract][Full Text] [Related]
17. Differential involvement of 5-HT(1A) and 5-HT(1B/1D) receptors in human interferon-alpha-induced immobility in the mouse forced swimming test.
Zhang H; Wang W; Jiang Z; Shang J; Zhang L
Arzneimittelforschung; 2010; 60(3):109-15. PubMed ID: 20422941
[TBL] [Abstract][Full Text] [Related]
18. Memory effects of the Ca2+ and 5-HT antagonists dotarizine and flunarizine.
Petkov VD; Konstantinova E; Petkov VV; Belcheva S; Kehayov R; Vaglenova J
Acta Physiol Pharmacol Bulg; 2000; 25(2):43-50. PubMed ID: 11140170
[TBL] [Abstract][Full Text] [Related]
19. Tonic immobility in guinea pigs: a behavioural response for detecting an anxiolytic-like effect?
Olsen CK; Hogg S; Lapiz MD
Behav Pharmacol; 2002 Jul; 13(4):261-9. PubMed ID: 12218506
[TBL] [Abstract][Full Text] [Related]
20. 5HT(1A) and 5HT(1B) receptors of medial prefrontal cortex modulate anxiogenic-like behaviors in rats.
Solati J; Salari AA; Bakhtiari A
Neurosci Lett; 2011 Oct; 504(3):325-9. PubMed ID: 21982809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
